Flexible Aptamer-Based Nucleolin-Targeting Cancer Treatment Modalities: A Focus on Immunotherapy, Radiotherapy, and Phototherapy

AuthorPouya Safarzadeh Kozanien
AuthorPooria Safarzadeh Kozanien
AuthorFatemeh Rahbarizadehen
OrcidPouya Safarzadeh Kozani [0000-0002-2602-3871]en
OrcidPooria Safarzadeh Kozani [0000-0002-9901-7851]en
OrcidFatemeh Rahbarizadeh [0000-0003-0890-8366]en
Issued Date2021-08-31en
AbstractCancer radiotherapy and phototherapy have been known as alternative approaches for the treatment of chemotherapy-resistant malignancies. Additionally, cancer immunotherapy has recently demonstrated to be a potential cancer treatment modality that has had its ups and downs despite the heart-warming outcomes it has achieved. However, researchers have proved that nanotechnology-facilitated approaches might bring the success of these modalities to an upper class. The nucleolin-targeting aptamer, AS1411, is among various aptamers utilized for the redirection of nanocarriers carrying radiosensitizers and photosensitizers. Recently, the potential applicability of this aptamer has been investigated in cancer immunotherapy. In this review, we discuss how aptamer-mediated nucleolin targeting nanoplatforms might ameliorate the side effects of cancer radiotherapy, phototherapy, and immunotherapy and improve the outcomes of these treatment approaches.en
DOIhttps://doi.org/10.5812/tms.113991en
KeywordNanocarriersen
KeywordRadiosensitizeren
KeywordPhotosensitizeren
KeywordImmunotherapyen
KeywordAS1411en
KeywordNucleolinen
PublisherBrieflandsen
TitleFlexible Aptamer-Based Nucleolin-Targeting Cancer Treatment Modalities: A Focus on Immunotherapy, Radiotherapy, and Phototherapyen
TypeReview Articleen

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
tms-1-3-113991.pdf
Size:
125.25 KB
Format:
Adobe Portable Document Format
Description:
Article/s PDF